Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 146
interventional 107
Observational 32
Registry 7

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 28
Drug|placebo 28
Other 16
Device 12
Drug|Other 4
Procedure 4
Behavioral 3
Biological 2
Device|Other 2
Device|Procedure 2
Behavioral|Device 1
Biological|placebo 1
Diagnostic Test 1
Dietary Supplement|Other 1
Other|Procedure 1
placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
China 14
United Kingdom 12
United States 9
Brazil 8
Spain 7
Turkey 5
Australia 4
NA 4
Netherlands 4
Canada 3
Belgium 2
Germany 2
Italy 2
Malaysia 2
Australia|Belgium|Germany|Greece|Israel|Italy|Netherlands|New Zealand|Portugal|Spain|Switzerland|United Kingdom 1
Australia|New Zealand 1
Australia|New Zealand|United Kingdom 1
Belgium|France|Germany|Italy|Spain|United Kingdom 1
Bulgaria|United States|Argentina|Australia|Austria|Brazil|China|Czechia|Germany|Hong Kong|Korea, Republic of|Latvia|Lithuania|Netherlands|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Taiwan|Thailand|Turkey 1
Canada|United Kingdom 1
Czech Republic|Poland|United Kingdom 1
Egypt 1
France 1
France|Germany|Italy|Spain|United Kingdom 1
Hong Kong 1
India 1
Israel 1
Italy|United States|Australia|Canada|Germany|Hungary|Ireland|Israel|Korea, Republic of|Latvia|Poland|Romania|South Africa|Spain|Taiwan|United Kingdom 1
Korea, Republic of 1
Russian Federation 1
Taiwan 1
Thailand 1
United States|Argentina|Australia|Belgium|Chile|Germany|Netherlands|New Zealand|United Kingdom 1
United States|Argentina|Australia|Canada|France|Germany|Greece|Israel|Italy|New Zealand|Poland|Portugal 1
United States|Argentina|Australia|Denmark|France|Germany|Israel|Italy|Japan|Latvia|New Zealand|Slovakia|Spain|United Kingdom 1
United States|Australia|Austria|Canada 1
United States|Australia|Belgium|Bulgaria|Denmark|Germany|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Singapore|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|Former Serbia and Montenegro|France|Georgia|Hungary|Israel|Italy|Korea, Republic of|New Zealand|Peru|Poland|Romania|Spain|United Kingdom 1
United States|Australia|Germany|Spain|Sweden|United Kingdom 1
United States|Bulgaria|Greece|Hungary|India|Poland|Serbia|Ukraine|United Kingdom 1
United States|Canada|Germany|United Kingdom 1

Sites per Study

Site_count Study_Count
1 72
2 7
3 1
5 1
6 1
9 1
10 2
13 1
15 1
16 1
18 1
19 1
22 2
24 1
33 1
36 1
37 1
47 1
60 1
83 1
85 1
95 2
108 1
109 1
115 1
151 1
207 1

Phase

Phase Study_Count
N/A 45
Phase 3 20
Phase 4 14
Phase 2 12
Phase 1 8
Phase 1/Phase 2 5
Phase 2/Phase 3 3

Number of Arms

Number_of_Arms Count_of_Studies
1 23
2 63
3 14
4 5
9 1
NA 1

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 5.00000 6.00 8.0 7.00000 20.00000 40.00 20.00000
1st Qu. 30.00000 27.50 10.0 36.00000 30.00000 72.00 52.50000
Median 44.00000 40.50 15.0 86.00000 40.00000 276.00 84.00000
Mean 62.62222 44.25 20.6 83.91667 39.33333 256.75 85.78571
3rd Qu. 71.00000 54.00 20.0 98.00000 49.00000 389.00 100.00000
Max. 210.00000 103.00 50.0 256.00000 58.00000 521.00 196.00000

Trial Group Type

group_type Group_Count
Experimental 94
Active Comparator 51
Placebo Comparator 47
No Intervention 13
Other 13
Sham Comparator 2
NA 1

Intervention Model

intervention_model Study_Count
Parallel Assignment 67
Single Group Assignment 26
Crossover Assignment 12
Factorial Assignment 1
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 88
Prevention 5
Basic Science 4
Other 4
Supportive Care 3
NA 2
Diagnostic 1

Observational Studies

Studies by Country

Country Study_Count
China 7
United Kingdom 5
NA 4
United States 4
Turkey 3
Australia 2
Belgium 2
France 2
Egypt 1
Italy 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 27
2 1
3 1
4 1
6 1
7 1

Enrollment Metrics

Measure Observational
Min 15.000
1st Qu 72.000
Median 120.000
Mean 3008.625
3rd Qu 258.500
Max 90089.000

Observation Model

observational_model Study_Count
Cohort 19
Case-Control 7
Case-Only 2
Other 2
Case Control 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 19
Cross-Sectional 6
Retrospective 5
Other 1
NA 1

Registries

Studies by Country

Country Study_Count
Korea, Republic of 3
Belgium 1
China 1
Italy 1
United States 1

Sites per Study

Site_count Study_Count
1 4
2 1
3 1
6 1

Enrollment Metrics

Measure Registries
Min 20.000
1st Qu 399.500
Median 800.000
Mean 2598.714
3rd Qu 3286.000
Max 10000.000

Registry Model

observational_model Study_Count
Cohort 6
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 7

Follow-up

target_duration Study_Count
20 Years 2
10 Years 1
18 Months 1
3 Years 1
5 Years 1
6 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03561818 Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis https://ClinicalTrials.gov/show/NCT03561818 Recruiting Istanbul Medipol University Hospital 2020-12-30
NCT02514226 Evaluation of Periodontal Treatment in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT02514226 Enrolling by invitation University of Nove de Julho 2020-07-31
NCT03218917 Assessment of INS1007 in Subjects With Non-Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT03218917 Completed Insmed Incorporated 2019-12-12
NCT03058718 Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis https://ClinicalTrials.gov/show/NCT03058718 Completed Qilu Hospital of Shandong University 2016-07-01
NCT03056326 A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Healthy Subjects https://ClinicalTrials.gov/show/NCT03056326 Completed Chiesi Farmaceutici S.p.A. 2017-07-31
NCT03013452 Oscillating PEP vs Autogenic Drainage in People With Bronchiectasis https://ClinicalTrials.gov/show/NCT03013452 Recruiting Carmel Medical Center 2019-12-30
NCT02883101 The Effects of Pulmonary Rehabilitation in Patients With Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT02883101 Completed All India Institute of Medical Sciences, New Delhi 2016-10-31
NCT02859194 The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients https://ClinicalTrials.gov/show/NCT02859194 Completed Yonsei University 2016-10-14
NCT02782312 Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT02782312 Completed Shanghai Pulmonary Hospital, Shanghai, China 2012-06-30
NCT02765295 Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis: A Randomized, Multi-center, Double-blind Study https://ClinicalTrials.gov/show/NCT02765295 Recruiting Guangzhou Institute of Respiratory Disease 2021-12-31
NCT02731482 Short-and Long-term Effects of a Home-based Rehabilitation Program in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT02731482 Completed University of Nove de Julho 2019-08-31
NCT02722642 Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis https://ClinicalTrials.gov/show/NCT02722642 Recruiting Regend Therapeutics 2020-06-30
NCT02712983 Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients With Non-Cystic Fibrosis Bronchiectasis and Pulmonary P. Aeruginosa Infection https://ClinicalTrials.gov/show/NCT02712983 Completed Novartis 2019-03-20
NCT02661438 Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo https://ClinicalTrials.gov/show/NCT02661438 Completed Bayer 2016-03-17
NCT02657473 Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT02657473 Completed Medical Center Alkmaar 2019-12-13
NCT02656992 Effects of High Intensity Inspiratory Muscle Training on Exercise Capacity in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT02656992 Completed Hacettepe University 2017-12-25
NCT02625246 Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non‐Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT02625246 Completed University of Miami 2019-05-15
NCT02598999 Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients https://ClinicalTrials.gov/show/NCT02598999 Recruiting Alaxia SAS 2020-02-29
NCT02035488 Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT02035488 Completed University Medical Center Groningen 2014-12-31
NCT02563197 Inhalation Flow Rate-study https://ClinicalTrials.gov/show/NCT02563197 Completed Bayer 2016-02-17
NCT02546297 Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis https://ClinicalTrials.gov/show/NCT02546297 Enrolling by invitation Shanghai Pulmonary Hospital, Shanghai, China 2020-09-15
NCT02509091 Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis https://ClinicalTrials.gov/show/NCT02509091 Recruiting Shanghai Pulmonary Hospital, Shanghai, China 2019-03-31
NCT02491723 Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa https://ClinicalTrials.gov/show/NCT02491723 Completed Shanghai Pulmonary Hospital, Shanghai, China 2016-01-31
NCT02468908 Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects https://ClinicalTrials.gov/show/NCT02468908 Completed Savara Inc. 2015-10-31
NCT01684683 The Effect of Theophylline in the Treatment of Bronchiectasis https://ClinicalTrials.gov/show/NCT01684683 Completed The First Affiliated Hospital of Guangzhou Medical University 2014-04-30
NCT02411981 Effects of Chest Physiotherapy (CPT) on Lung Clearance Index (LCI) in Non Cystic Fibrosis (CF) Bronchiectasis https://ClinicalTrials.gov/show/NCT02411981 Completed Cliniques universitaires Saint-Luc- Université Catholique de Louvain 2015-10-31
NCT02392663 Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT02392663 Completed Hospital Clinic of Barcelona 2015-12-31
NCT02324855 Long-term Airway Clearance Therapy in Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT02324855 Active, not recruiting Universidad San Jorge 2020-06-30
NCT02315547 Sputum Microbiota and the Association With Clinical Parameters in Steady-state, Acute Exacerbation and Convalescence of Bronchiectasis https://ClinicalTrials.gov/show/NCT02315547 Recruiting Guangzhou Institute of Respiratory Disease 2023-12-31
NCT02282202 Evaluation of Oscillatory Positive Expiratory Pressure (oPEP) in Bronchiectasis and COPD https://ClinicalTrials.gov/show/NCT02282202 Completed Western University, Canada 2014-09-30
NCT02279329 Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging https://ClinicalTrials.gov/show/NCT02279329 Recruiting Western University, Canada 2022-03-31
NCT02208830 Physical Capacity in Patients With Bronchiectasis Before and After Rehabilitation Program https://ClinicalTrials.gov/show/NCT02208830 Completed University of Nove de Julho 2015-12-31
NCT02107274 Efficacy of Azithromycin in Treatment of Bronchiectasis https://ClinicalTrials.gov/show/NCT02107274 Completed Penang Hospital, Malaysia 2013-12-31
NCT02106832 Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) https://ClinicalTrials.gov/show/NCT02106832 Completed Bayer 2016-09-13
NCT02104245 Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) https://ClinicalTrials.gov/show/NCT02104245 Completed Aradigm Corporation 2016-08-31
NCT02088216 Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis https://ClinicalTrials.gov/show/NCT02088216 Completed Qilu Hospital of Shandong University 2017-12-01
NCT02081963 Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT02081963 Completed Qilu Hospital of Shandong University 2016-03-31
NCT01314716 Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01314716 Completed Gilead Sciences 2013-04-30
NCT01313624 Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01313624 Completed Gilead Sciences 2013-03-31
NCT03383939 Inhaled A1AT in Adult Stable Bronchiectasis https://ClinicalTrials.gov/show/NCT03383939 Completed Hospital Universitari Vall d’Hebron Research Institute 1999-09-07
NCT01300403 Physiological Effects of Expiration With the Glottis Open in Lateral Posture (ELTGOL) and Flutter Valve in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT01300403 Completed Universidade Federal do Rio de Janeiro 2010-08-31
NCT01299194 Atorvastatin in Bronchiectasis in Patients With Pseudomonas Aeruginosa https://ClinicalTrials.gov/show/NCT01299194 Completed University of Edinburgh 2015-06-30
NCT01299181 A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01299181 Completed University of Edinburgh 2013-08-31
NCT01270074 Prevention of Bronchiectasis in Infants With Cystic Fibrosis https://ClinicalTrials.gov/show/NCT01270074 Active, not recruiting Queensland Children’s Medical Research Institute 2020-05-31
NCT02048397 Pulmonary Rehabilitation Program (PRP) Versus PRP Plus Nutritional Supplementation in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT02048397 Completed Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 2014-09-30
NCT02047773 Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations https://ClinicalTrials.gov/show/NCT02047773 Completed University of Edinburgh 2020-02-01
NCT03093974 Long Term Efficacy and Safety of Inhaled Colistimethate Sodium in Bronchiectasis Subjects With Chronic Pseudomonas Aeruginosa Infection. https://ClinicalTrials.gov/show/NCT03093974 Recruiting Zambon SpA 2021-05-31
NCT03460704 Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium (PROMIS II) https://ClinicalTrials.gov/show/NCT03460704 Recruiting Zambon SpA 2021-11-30
NCT01968421 Prevention of OM-85 on Bronchiectasis Exacerbation https://ClinicalTrials.gov/show/NCT01968421 Completed Chinese Academy of Medical Sciences 2018-11-23
NCT01854788 3 Airway Clearance Techniques in Non Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01854788 Completed Hospital Clinic of Barcelona 2012-06-30
NCT01818544 Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis https://ClinicalTrials.gov/show/NCT01818544 Completed Bayer 2014-06-30
NCT01764841 Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) https://ClinicalTrials.gov/show/NCT01764841 Completed Bayer 2016-03-09
NCT01761214 Bacteriology and Inflammation in Bronchiectasis https://ClinicalTrials.gov/show/NCT01761214 Recruiting Guangzhou Institute of Respiratory Disease 2023-12-31
NCT01615484 Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability https://ClinicalTrials.gov/show/NCT01615484 Completed University of North Carolina, Chapel Hill 2016-03-31
NCT01578681 ELTGOL and Bronchiectasis. Respiratory Therapy https://ClinicalTrials.gov/show/NCT01578681 Completed Institut d’Investigació Biomèdica de Girona Dr. Josep Trueta 2011-09-30
NCT01515007 Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3) https://ClinicalTrials.gov/show/NCT01515007 Completed Aradigm Corporation 2016-08-31
NCT01480882 Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory Passage https://ClinicalTrials.gov/show/NCT01480882 Completed Penang Hospital, Malaysia 2012-06-30
NCT01463371 Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT01463371 Completed Instituto de Investigacion Sanitaria La Fe 2007-04-30
NCT01769898 The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis https://ClinicalTrials.gov/show/NCT01769898 Completed The First Affiliated Hospital of Guangzhou Medical University 2014-09-30
NCT04411901 The Role of Vitamin D3 in Pediatric Bronchiectasis Severity https://ClinicalTrials.gov/show/NCT04411901 Completed Ain Shams University 2018-09-06
NCT04266873 Feasibility Study of the AffloVest in Bronchiectasis https://ClinicalTrials.gov/show/NCT04266873 Recruiting Papworth Hospital NHS Foundation Trust 2020-08-31
NCT04278040 Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT04278040 Recruiting Federal State Budgetary Institution, Pulmonology Scientific Research Institute 2021-12-01
NCT04234789 Predictors of Physical Activity Performance and Dynamic Hyperinflation in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT04234789 Completed University of Sao Paulo General Hospital 2014-05-31
NCT04170114 Comparison of the Efficacy of Comprehensive Respiratory Physiotherapy in Children With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT04170114 Recruiting Bezmialem Vakif University 2020-12-30
NCT04140214 Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR) https://ClinicalTrials.gov/show/NCT04140214 Recruiting Belfast Health and Social Care Trust 2021-08-31
NCT04122547 Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT04122547 Completed Prince of Songkla University 2015-12-31
NCT04122040 Effects of Roxithromycin on Quality of Life and Physiological Outcomes in Bronchiectasis https://ClinicalTrials.gov/show/NCT04122040 Completed Prince of Songkla University 2011-09-30
NCT04142827 The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX) https://ClinicalTrials.gov/show/NCT04142827 Recruiting Monaldi Hospital 2020-03-03
NCT04102774 Effect of AIRVO Heated Humidification in Bronchiectasis https://ClinicalTrials.gov/show/NCT04102774 Recruiting Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico 2022-06-20
NCT04038892 The Effect of Different Virtual Reality-Based Exercise Trainings on Pulmonary Function, Respiratory and Peripheral Muscle Strength, Functional Capacity and Balance in Children With Bronchiectasis https://ClinicalTrials.gov/show/NCT04038892 Recruiting Bezmialem Vakif University 2020-12-01
NCT04017312 A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting https://ClinicalTrials.gov/show/NCT04017312 Recruiting Hill-Rom 2020-11-30
NCT04010799 A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis https://ClinicalTrials.gov/show/NCT04010799 Recruiting Chiesi Farmaceutici S.p.A. 2020-07-31
NCT03988816 Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT03988816 Recruiting University of Sao Paulo General Hospital 2020-12-31
NCT03920124 Feasibility of Interval Exercise in Bronchiectasis https://ClinicalTrials.gov/show/NCT03920124 Completed University of Lincoln 2019-09-05
NCT03846570 Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT03846570 Recruiting Erasmus Medical Center 2019-12-31
NCT03829618 Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound https://ClinicalTrials.gov/show/NCT03829618 Recruiting Milton S. Hershey Medical Center 2020-07-01
NCT03628456 Effect of HFCWO Vests on Spirometry Measurements https://ClinicalTrials.gov/show/NCT03628456 Completed International Biophysics Corporation 2018-09-21
NCT03534986 Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements https://ClinicalTrials.gov/show/NCT03534986 Completed International Biophysics Corporation 2018-03-16
NCT03455686 Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease https://ClinicalTrials.gov/show/NCT03455686 Recruiting McMaster University 2023-03-31
NCT03428334 Roflumilast in Non-CF Bronchiectasis Study https://ClinicalTrials.gov/show/NCT03428334 Completed The University of Hong Kong 2019-08-31
NCT03420209 The Effect of Proprioceptive Neuromuscular Facilitation (PNF) Technique for Children With Chronic Pulmonary Diseases. https://ClinicalTrials.gov/show/NCT03420209 Active, not recruiting Istanbul University 2020-11-01
NCT01255592 Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT01255592 Completed AstraZeneca 2012-02-29
NCT01117493 Expert Patient Self-management Programme Versus Usual Care in Bronchiectasis https://ClinicalTrials.gov/show/NCT01117493 Completed Belfast Health and Social Care Trust 2007-10-31
NCT01113034 A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis https://ClinicalTrials.gov/show/NCT01113034 Completed Ansun Biopharma, Inc. 2011-08-22
NCT01076491 High Dose Inhaled Mannitol Study https://ClinicalTrials.gov/show/NCT01076491 Completed Pharmaxis 2009-03-31
NCT00952718 Effects of Inspiratory Muscle Training in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT00952718 Completed Chang Gung Memorial Hospital 2008-12-31
NCT00930982 Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT00930982 Completed Bayer 2010-09-30
NCT00889967 Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis “ORBIT-1” https://ClinicalTrials.gov/show/NCT00889967 Completed Aradigm Corporation 2011-04-30
NCT00885521 Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis https://ClinicalTrials.gov/show/NCT00885521 Completed Bayside Health 2013-02-28
NCT00868075 Pulmonary Rehabilitation in Non Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT00868075 Completed NHS Lothian 2011-08-31
NCT03715322 Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa https://ClinicalTrials.gov/show/NCT03715322 Recruiting Guangzhou Institute of Respiratory Disease 2021-04-30
NCT00816309 Is Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis? https://ClinicalTrials.gov/show/NCT00816309 Completed NHS Lothian 2008-12-31
NCT00805025 Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT00805025 Completed Gilead Sciences 2009-10-31
NCT02509637 Acute Effects of a Flutter Device and Chest Wall Compression on Respiratory System Impedance in Bronchiectasis Patients https://ClinicalTrials.gov/show/NCT02509637 Completed University of Sao Paulo 2016-09-30
NCT00775138 Safety and Tolerability Study of 2 Dose Level of Arikayceâ„¢ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa. https://ClinicalTrials.gov/show/NCT00775138 Completed Insmed Incorporated 2009-05-11
NCT00769119 A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT00769119 Completed AstraZeneca 2009-04-30
NCT00749866 Long Term Nebulised Gentamicin in Patients With Bronchiectasis https://ClinicalTrials.gov/show/NCT00749866 Completed University of Edinburgh 2009-08-31
NCT00728715 Efficacy of Budesonide-Formoterol in Bronchiectasis https://ClinicalTrials.gov/show/NCT00728715 Completed Hospital General de Requena 2005-01-31
NCT00730977 A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device https://ClinicalTrials.gov/show/NCT00730977 Completed Pharmaxis 2008-09-30
NCT00669331 Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis https://ClinicalTrials.gov/show/NCT00669331 Completed Pharmaxis 2014-01-31
NCT00656721 Respiratory Mechanics Effects of Flutter Valve in Bronchiectasis Patients https://ClinicalTrials.gov/show/NCT00656721 Completed Universidade Federal do Rio de Janeiro 2005-11-30
NCT00522314 Airway Clearance in Bronchiectasis: is Non-Invasive Ventilation a Useful Adjunct in Moderate to Severe Disease? https://ClinicalTrials.gov/show/NCT00522314 Completed University of Ulster NA
NCT00484263 The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT00484263 Completed The Alfred 2009-10-31
NCT00415350 Bronchiectasis and Long Term Azithromycin Treatment https://ClinicalTrials.gov/show/NCT00415350 Completed Medical Center Alkmaar 2009-12-31
NCT00277537 Safety and Efficacy of Bronchitol in Bronchiectasis https://ClinicalTrials.gov/show/NCT00277537 Completed Pharmaxis 2008-07-31
NCT00129701 Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation https://ClinicalTrials.gov/show/NCT00129701 Completed Imperial College London 2005-10-31
NCT00105183 EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection https://ClinicalTrials.gov/show/NCT00105183 Completed Neovii Biotech 2010-01-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03320382 Multiple Breath Washout, a Clinimetric Dataset https://ClinicalTrials.gov/show/NCT03320382 Recruiting Imperial College London 2021-03-31
NCT03125174 Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls https://ClinicalTrials.gov/show/NCT03125174 Completed University of North Carolina, Chapel Hill 2017-06-27
NCT02804971 Cardiovascular Comorbidities and Bronchiectasis https://ClinicalTrials.gov/show/NCT02804971 Recruiting Centre Hospitalier Intercommunal Creteil 2019-11-30
NCT02779478 Evaluation Of The Lung Microbiome In NTM Bronchiectasis https://ClinicalTrials.gov/show/NCT02779478 Recruiting NYU Langone Health 2024-07-31
NCT02714283 Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis https://ClinicalTrials.gov/show/NCT02714283 Completed Oregon Health and Science University 2018-06-30
NCT01264055 Cross-sectional Characterization of Idiopathic Bronchiectasis https://ClinicalTrials.gov/show/NCT01264055 Completed National Institutes of Health Clinical Center (CC) NA
NCT02564731 Prognosis of Bronchiectasis in Children–A Multicenter Prospective Cohort Study https://ClinicalTrials.gov/show/NCT02564731 Recruiting Beijing Children’s Hospital 2022-03-31
NCT03643302 Airway Clearance and Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation https://ClinicalTrials.gov/show/NCT03643302 Completed Shanghai Pulmonary Hospital, Shanghai, China 2019-02-28
NCT02555865 Aetiology of Children With Bronchiectasis in China https://ClinicalTrials.gov/show/NCT02555865 Recruiting Beijing Children’s Hospital 2022-03-31
NCT02468271 Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK https://ClinicalTrials.gov/show/NCT02468271 Active, not recruiting Queen’s University, Belfast 2018-05-31
NCT01792427 Mortality in Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01792427 Completed Universitaire Ziekenhuizen Leuven 2012-10-31
NCT01569009 Physical Activity in Bronchiectasis https://ClinicalTrials.gov/show/NCT01569009 Completed University of Ulster 2013-07-31
NCT04435327 Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19) https://ClinicalTrials.gov/show/NCT04435327 Recruiting University of Milano Bicocca 2021-04-30
NCT04271969 Clinical Effectiveness Of High Frequency Chest Wall Oscillation (HFCWO) In A Bronchiectasis Population https://ClinicalTrials.gov/show/NCT04271969 Recruiting Electromed, Inc. 2021-06-30
NCT04153448 Comparison of Sit-to-stand Test With Six-minute Walk Test in Bronchiectasis and Healthy Children https://ClinicalTrials.gov/show/NCT04153448 Completed Bezmialem Vakif University 2020-01-30
NCT04101448 Prevalence of Bronchiectasis in COPD Patients https://ClinicalTrials.gov/show/NCT04101448 Recruiting Assiut University 2020-09-01
NCT04081740 Biological Determinants of Sputum Rheology in Chronic Airway Diseases https://ClinicalTrials.gov/show/NCT04081740 Completed University Hospital, Montpellier 2019-10-15
NCT03950531 The Effect of Bronchiectasis on the Exacerbation and Mortality in COPD https://ClinicalTrials.gov/show/NCT03950531 Completed Ministry of Health, Turkey 2014-12-25
NCT03902236 Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis https://ClinicalTrials.gov/show/NCT03902236 Recruiting Hacettepe University 2019-10-07
NCT03883048 Analysis of the Severity and Prognosis of Pulmonary Hypertension Associated With Bronchiectasis. https://ClinicalTrials.gov/show/NCT03883048 Recruiting Shanghai Pulmonary Hospital, Shanghai, China 2020-02-01
NCT03791086 The BRIDGE Study - Bronchiectasis Research Involving Databases, Genomics and Endotyping https://ClinicalTrials.gov/show/NCT03791086 Recruiting University of Dundee 2023-02-01
NCT03670940 Bronchiectasis Effect in COPD Patients https://ClinicalTrials.gov/show/NCT03670940 Completed Izmir Katip Celebi University 2018-03-31
NCT03638063 ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis https://ClinicalTrials.gov/show/NCT03638063 Recruiting Guangzhou Institute of Respiratory Disease 2020-07-31
NCT03594032 Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria https://ClinicalTrials.gov/show/NCT03594032 Recruiting Capital Medical University 2020-12-31
NCT03550417 Evaluation of Medical and Nursing Management for Bronchiectasis https://ClinicalTrials.gov/show/NCT03550417 Active, not recruiting The Queen Elizabeth Hospital 2020-06-30
NCT00943514 Natural History of Bronchiectasis https://ClinicalTrials.gov/show/NCT00943514 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03643263 Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis https://ClinicalTrials.gov/show/NCT03643263 Recruiting Shanghai Pulmonary Hospital, Shanghai, China 2020-06-30
NCT02550821 Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects https://ClinicalTrials.gov/show/NCT02550821 Completed Hacettepe University 2016-08-31
NCT01792440 The Sputum Colour Chart as a Predictor of Lung Inflammation and Proteolysis in Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01792440 Completed Universitaire Ziekenhuizen Leuven 2010-07-31
NCT00697177 The Prevalence of Gastro-oesophageal Reflux in Chronic Lung Disease https://ClinicalTrials.gov/show/NCT00697177 Completed Bayside Health 2009-06-30
NCT00656565 Inspiratory Flow and Volumes in Bronchiectatics https://ClinicalTrials.gov/show/NCT00656565 Completed Pharmaxis 2008-07-31
NCT00487149 Respiratory Muscle Strength in Bronchiectasis: Repeatability and Reliability https://ClinicalTrials.gov/show/NCT00487149 Completed University of Ulster NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03120481 Controls for Respiratory Diseases https://ClinicalTrials.gov/show/NCT03120481 Recruiting Seoul National University Hospital 2037-02-28
NCT03643653 The Establishment of China Bronchiectasis Registry and Research Collaboration https://ClinicalTrials.gov/show/NCT03643653 Recruiting Shanghai Pulmonary Hospital, Shanghai, China 2025-12-31
NCT02527486 Seoul National University Airway Registry https://ClinicalTrials.gov/show/NCT02527486 Recruiting Seoul National University Hospital 2021-12-31
NCT02045394 Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study https://ClinicalTrials.gov/show/NCT02045394 Completed University of Milan 2015-10-31
NCT01906047 Impact of Chronic Air Pollution on Non-cystic Fibrosis Bronchiectasis https://ClinicalTrials.gov/show/NCT01906047 Completed Universitaire Ziekenhuizen Leuven 2012-10-31
NCT01822834 Bronchiectasis and NTM Research Registry https://ClinicalTrials.gov/show/NCT01822834 Recruiting COPD Foundation 2050-12-31
NCT03809091 WGS of Korean Idiopathic Bronchiectasis https://ClinicalTrials.gov/show/NCT03809091 Recruiting Seoul National University Hospital 2021-08-31